Related Experiment Video
Updated: Apr 7, 2026

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
Published on: October 20, 2020
Characterization of host response to Cryptococcus neoformans through quantitative proteomic analysis of cryptococcal
Lakshmi Dhevi N Selvan1, Sreelakshmi K Sreenivasamurthy, Satwant Kumar
1Institute of Bioinformatics, International Technology Park, Bangalore 560066, India. keshav@ibioinformatics.org.
Abstract:
Cryptococcal meningitis is the most common opportunistic fungal infection causing morbidity and mortality (>60%) in HIV-associated immunocompromised individuals caused by Cryptococcus neoformans. Molecular mechanisms of cryptococcal infection in brain have been studied using experimental animal models and cell lines. There are limited studies for the molecular understanding of cryptococcal meningitis in human brain. The proteins involved in the process of invasion and infection in human brain still remains obscure. To this end we carried out mass spectrometry-based quantitative proteomics of frontal lobe brain tissues from cryptococcal meningitis patients and controls to identify host proteins that are associated with the pathogenesis of cryptococcal meningitis. We identified 317 proteins to be differentially expressed (≥2-fold) from a total of 3423 human proteins. We found proteins involved in immune response and signal transduction to be differentially expressed in response to cryptococcal infection in human brain. Immune response proteins including complement factors, major histocompatibility proteins, proteins previously known to be involved in fungal invasion to brain such as caveolin 1 and actin were identified to be differentially expressed in cryptococcal meningitis brain tissues co-infected with HIV. We also validated the expression status of 5 proteins using immunohistochemistry. Overexpression of major histocompatibility complexes, class I, B (HLA-B), actin alpha 2 smooth muscle aorta (ACTA2) and caveolin 1 (CAV1) and downregulation of peripheral myelin protein 2 (PMP2) and alpha crystallin B chain (CRYAB) in cryptococcal meningitis were confirmed by IHC-based validation experiments. This study provides the brain proteome profile of cryptococcal meningitis co-infected with HIV for a better understanding of the host response associated with the disease.
Insights
This study reveals key host proteins involved in cryptococcal meningitis pathogenesis in HIV patients. Understanding these proteins, like HLA-B and caveolin 1, aids in developing targeted therapies for this severe fungal infection.
Area of Science:
- Neuroscience
- Mycology
- Immunology
Background:
- Cryptococcal meningitis is a leading cause of death in HIV-associated immunocompromised individuals.
- Molecular mechanisms of human brain infection by Cryptococcus neoformans remain poorly understood.
- Limited research exists on host protein involvement in human brain cryptococcal meningitis.
Purpose of the Study:
- To identify host proteins associated with cryptococcal meningitis pathogenesis in the human brain.
- To investigate the molecular mechanisms of fungal invasion and infection in the human brain.
Main Methods:
- Mass spectrometry-based quantitative proteomics was performed on frontal lobe brain tissues from patients with cryptococcal meningitis and controls.
- Differential protein expression analysis identified significant changes in host proteins.
- Immunohistochemistry was used to validate the expression status of key identified proteins.
Main Results:
- 317 out of 3423 human proteins showed differential expression (≥2-fold) in cryptococcal meningitis.
- Proteins involved in immune response and signal transduction were significantly altered.
- Upregulation of HLA-B, ACTA2, and CAV1, and downregulation of PMP2 and CRYAB were confirmed.
Conclusions:
- This study provides the first comprehensive brain proteome profile for HIV-associated cryptococcal meningitis.
- Identified proteins offer insights into host responses and potential therapeutic targets for cryptococcal meningitis.
- Understanding these host-pathogen interactions is crucial for improving outcomes in immunocompromised patients.

